2-cyclobutyl-5-(2,2-dimethylpropyl)-1,3,4-oxadiazole;2-(1,1-difluoroethyl)-5-(2,2-dimethylpropyl)pyridine;4-(1,1-difluoroethyl)-2-(2,2-dimethylpropyl)pyrimidine;5-[6-(1,1-difluoroethyl)-3-pyridinyl]-2-(2,2-dimethylpropyl)pyrimidine;N,N-dimethyl-2-(2-methylpropyl)pyrimidin-4-amine;2-(2,2-dimethylpropyl)-4,6-dimethoxypyrimidine;2-(2,2-dimethylpropyl)-4-methoxypyrimidine;2-(2,2-dimethylpropyl)-6-methylpyrazine;2-(2,2-dimethylpropyl)-4-methylpyrimidine;2-(2,2-dimethylpropyl)-4-piperidin-1-ylpyrimidine;6-(2,2-dimethylpropyl)pyridine-2-carbonitrile;3-(2,2-dimethylpropyl)-5-pyridin-2-yl-1,2-oxazole;2-(2,2-dimethylpropyl)-6-(trifluoromethyl)pyridine;2-methyl-5-(2-methylpropyl)pyrazine;4-[2-(2-methylpropyl)pyrimidin-4-yl]morpholine

C171H253F9N32O6 — CID 158440305

IUPAC2-cyclobutyl-5-(2,2-dimethylpropyl)-1,3,4-oxadiazole;2-(1,1-difluoroethyl)-5-(2,2-dimethylpropyl)pyridine;4-(1,1-difluoroethyl)-2-(2,2-dimethylpropyl)pyrimidine;5-[6-(1,1-difluoroethyl)-3-pyridinyl]-2-(2,2-dimethylpropyl)pyrimidine;N,N-dimethyl-2-(2-methylpropyl)pyrimidin-4-amine;2-(2,2-dimethylpropyl)-4,6-dimethoxypyrimidine;2-(2,2-dimethylpropyl)-4-methoxypyrimidine;2-(2,2-dimethylpropyl)-6-methylpyrazine;2-(2,2-dimethylpropyl)-4-methylpyrimidine;2-(2,2-dimethylpropyl)-4-piperidin-1-ylpyrimidine;6-(2,2-dimethylpropyl)pyridine-2-carbonitrile;3-(2,2-dimethylpropyl)-5-pyridin-2-yl-1,2-oxazole;2-(2,2-dimethylpropyl)-6-(trifluoromethyl)pyridine;2-methyl-5-(2-methylpropyl)pyrazine;4-[2-(2-methylpropyl)pyrimidin-4-yl]morpholine
SMILESCC(C)(C)Cc1cc(-c2ccccn2)on1.CC(C)(C)Cc1ccc(C(C)(F)F)nc1.CC(C)(C)Cc1cccc(C#N)n1.CC(C)(C)Cc1cccc(C(F)(F)F)n1.CC(C)(C)Cc1ncc(-c2ccc(C(C)(F)F)nc2)cn1.CC(C)(C)Cc1nccc(C(C)(F)F)n1.CC(C)(C)Cc1nccc(N2CCCCC2)n1.CC(C)(C)Cc1nnc(C2CCC2)o1.CC(C)Cc1nccc(N(C)C)n1.CC(C)Cc1nccc(N2CCOCC2)n1.COc1cc(OC)nc(CC(C)(C)C)n1.COc1ccnc(CC(C)(C)C)n1.Cc1ccnc(CC(C)(C)C)n1.Cc1cnc(CC(C)C)cn1.Cc1cncc(CC(C)(C)C)n1
InChIInChI=1S/C16H19F2N3.C14H23N3.C13H16N2O.C12H17F2N.C12H19N3O.C11H14F3N.C11H16F2N2.C11H18N2O2.C11H18N2O.C11H14N2.C10H17N3.C10H16N2O.2C10H16N2.C9H14N2/c1-15(2,3)7-14-20-9-12(10-21-14)11-5-6-13(19-8-11)16(4,17)18;1-14(2,3)11-12-15-8-7-13(16-12)17-9-5-4-6-10-17;1-13(2,3)9-10-8-12(16-15-10)11-6-4-5-7-14-11;1-11(2,3)7-9-5-6-10(15-8-9)12(4,13)14;1-10(2)9-11-13-4-3-12(14-11)15-5-7-16-8-6-15;1-10(2,3)7-8-5-4-6-9(15-8)11(12,13)14;1-10(2,3)7-9-14-6-5-8(15-9)11(4,12)13;1-11(2,3)7-8-12-9(14-4)6-10(13-8)15-5;1-11(2,3)7-9-12-13-10(14-9)8-5-4-6-8;1-11(2,3)7-9-5-4-6-10(8-12)13-9;1-8(2)7-9-11-6-5-10(12-9)13(3)4;1-10(2,3)7-8-11-6-5-9(12-8)13-4;1-8-6-11-7-9(12-8)5-10(2,3)4;1-8-5-6-11-9(12-8)7-10(2,3)4;1-7(2)4-9-6-10-8(3)5-11-9/h5-6,8-10H,7H2,1-4H3;7-8H,4-6,9-11H2,1-3H3;4-8H,9H2,1-3H3;5-6,8H,7H2,1-4H3;3-4,10H,5-9H2,1-2H3;4-6H,7H2,1-3H3;5-6H,7H2,1-4H3;6H,7H2,1-5H3;8H,4-7H2,1-3H3;4-6H,7H2,1-3H3;5-6,8H,7H2,1-4H3;5-6H,7H2,1-4H3;6-7H,5H2,1-4H3;5-6H,7H2,1-4H3;5-7H,4H2,1-3H3
InChIKeyHCSTYHDUSJOJFN-UHFFFAOYSA-N
MW3024.10 g/mol
LogP40.87
Rot. Bonds30

About 2-cyclobutyl-5-(2,2-dimethylpropyl)-1,3,4-oxadiazole;2-(1,1-difluoroethyl)-5-(2,2-dimethylpropyl)pyridine;4-(1,1-difluoroethyl)-2-(2,2-dimethylpropyl)pyrimidine;5-[6-(1,1-difluoroethyl)-3-pyridinyl]-2-(2,2-dimethylpropyl)pyrimidine;N,N-dimethyl-2-(2-methylpropyl)pyrimidin-4-amine;2-(2,2-dimethylpropyl)-4,6-dimethoxypyrimidine;2-(2,2-dimethylpropyl)-4-methoxypyrimidine;2-(2,2-dimethylpropyl)-6-methylpyrazine;2-(2,2-dimethylpropyl)-4-methylpyrimidine;2-(2,2-dimethylpropyl)-4-piperidin-1-ylpyrimidine;6-(2,2-dimethylpropyl)pyridine-2-carbonitrile;3-(2,2-dimethylpropyl)-5-pyridin-2-yl-1,2-oxazole;2-(2,2-dimethylpropyl)-6-(trifluoromethyl)pyridine;2-methyl-5-(2-methylpropyl)pyrazine;4-[2-(2-methylpropyl)pyrimidin-4-yl]morpholine

2-cyclobutyl-5-(2,2-dimethylpropyl)-1,3,4-oxadiazole;2-(1,1-difluoroethyl)-5-(2,2-dimethylpropyl)pyridine;4-(1,1-difluoroethyl)-2-(2,2-dimethylpropyl)pyrimidine;5-[6-(1,1-difluoroethyl)-3-pyridinyl]-2-(2,2-dimethylpropyl)pyrimidine;N,N-dimethyl-2-(2-methylpropyl)pyrimidin-4-amine;2-(2,2-dimethylpropyl)-4,6-dimethoxypyrimidine;2-(2,2-dimethylpropyl)-4-methoxypyrimidine;2-(2,2-dimethylpropyl)-6-methylpyrazine;2-(2,2-dimethylpropyl)-4-methylpyrimidine;2-(2,2-dimethylpropyl)-4-piperidin-1-ylpyrimidine;6-(2,2-dimethylpropyl)pyridine-2-carbonitrile;3-(2,2-dimethylpropyl)-5-pyridin-2-yl-1,2-oxazole;2-(2,2-dimethylpropyl)-6-(trifluoromethyl)pyridine;2-methyl-5-(2-methylpropyl)pyrazine;4-[2-(2-methylpropyl)pyrimidin-4-yl]morpholine (PubChem CID 158440305) has the molecular formula C171H253F9N32O6 and a molecular weight of 3024.10 g/mol. Its IUPAC name is 2-cyclobutyl-5-(2,2-dimethylpropyl)-1,3,4-oxadiazole;2-(1,1-difluoroethyl)-5-(2,2-dimethylpropyl)pyridine;4-(1,1-difluoroethyl)-2-(2,2-dimethylpropyl)pyrimidine;5-[6-(1,1-difluoroethyl)-3-pyridinyl]-2-(2,2-dimethylpropyl)pyrimidine;N,N-dimethyl-2-(2-methylpropyl)pyrimidin-4-amine;2-(2,2-dimethylpropyl)-4,6-dimethoxypyrimidine;2-(2,2-dimethylpropyl)-4-methoxypyrimidine;2-(2,2-dimethylpropyl)-6-methylpyrazine;2-(2,2-dimethylpropyl)-4-methylpyrimidine;2-(2,2-dimethylpropyl)-4-piperidin-1-ylpyrimidine;6-(2,2-dimethylpropyl)pyridine-2-carbonitrile;3-(2,2-dimethylpropyl)-5-pyridin-2-yl-1,2-oxazole;2-(2,2-dimethylpropyl)-6-(trifluoromethyl)pyridine;2-methyl-5-(2-methylpropyl)pyrazine;4-[2-(2-methylpropyl)pyrimidin-4-yl]morpholine.

Molecular Properties

Compound Name2-cyclobutyl-5-(2,2-dimethylpropyl)-1,3,4-oxadiazole;2-(1,1-difluoroethyl)-5-(2,2-dimethylpropyl)pyridine;4-(1,1-difluoroethyl)-2-(2,2-dimethylpropyl)pyrimidine;5-[6-(1,1-difluoroethyl)-3-pyridinyl]-2-(2,2-dimethylpropyl)pyrimidine;N,N-dimethyl-2-(2-methylpropyl)pyrimidin-4-amine;2-(2,2-dimethylpropyl)-4,6-dimethoxypyrimidine;2-(2,2-dimethylpropyl)-4-methoxypyrimidine;2-(2,2-dimethylpropyl)-6-methylpyrazine;2-(2,2-dimethylpropyl)-4-methylpyrimidine;2-(2,2-dimethylpropyl)-4-piperidin-1-ylpyrimidine;6-(2,2-dimethylpropyl)pyridine-2-carbonitrile;3-(2,2-dimethylpropyl)-5-pyridin-2-yl-1,2-oxazole;2-(2,2-dimethylpropyl)-6-(trifluoromethyl)pyridine;2-methyl-5-(2-methylpropyl)pyrazine;4-[2-(2-methylpropyl)pyrimidin-4-yl]morpholine
PubChem CID158440305
Molecular FormulaC171H253F9N32O6
Molecular Weight3024.10 g/mol
Exact Mass3022.03
IUPAC Name2-cyclobutyl-5-(2,2-dimethylpropyl)-1,3,4-oxadiazole;2-(1,1-difluoroethyl)-5-(2,2-dimethylpropyl)pyridine;4-(1,1-difluoroethyl)-2-(2,2-dimethylpropyl)pyrimidine;5-[6-(1,1-difluoroethyl)-3-pyridinyl]-2-(2,2-dimethylpropyl)pyrimidine;N,N-dimethyl-2-(2-methylpropyl)pyrimidin-4-amine;2-(2,2-dimethylpropyl)-4,6-dimethoxypyrimidine;2-(2,2-dimethylpropyl)-4-methoxypyrimidine;2-(2,2-dimethylpropyl)-6-methylpyrazine;2-(2,2-dimethylpropyl)-4-methylpyrimidine;2-(2,2-dimethylpropyl)-4-piperidin-1-ylpyrimidine;6-(2,2-dimethylpropyl)pyridine-2-carbonitrile;3-(2,2-dimethylpropyl)-5-pyridin-2-yl-1,2-oxazole;2-(2,2-dimethylpropyl)-6-(trifluoromethyl)pyridine;2-methyl-5-(2-methylpropyl)pyrazine;4-[2-(2-methylpropyl)pyrimidin-4-yl]morpholine
SMILESCC(C)(C)Cc1cc(-c2ccccn2)on1.CC(C)(C)Cc1ccc(C(C)(F)F)nc1.CC(C)(C)Cc1cccc(C#N)n1.CC(C)(C)Cc1cccc(C(F)(F)F)n1.CC(C)(C)Cc1ncc(-c2ccc(C(C)(F)F)nc2)cn1.CC(C)(C)Cc1nccc(C(C)(F)F)n1.CC(C)(C)Cc1nccc(N2CCCCC2)n1.CC(C)(C)Cc1nnc(C2CCC2)o1.CC(C)Cc1nccc(N(C)C)n1.CC(C)Cc1nccc(N2CCOCC2)n1.COc1cc(OC)nc(CC(C)(C)C)n1.COc1ccnc(CC(C)(C)C)n1.Cc1ccnc(CC(C)(C)C)n1.Cc1cnc(CC(C)C)cn1.Cc1cncc(CC(C)(C)C)n1
InChIInChI=1S/C16H19F2N3.C14H23N3.C13H16N2O.C12H17F2N.C12H19N3O.C11H14F3N.C11H16F2N2.C11H18N2O2.C11H18N2O.C11H14N2.C10H17N3.C10H16N2O.2C10H16N2.C9H14N2/c1-15(2,3)7-14-20-9-12(10-21-14)11-5-6-13(19-8-11)16(4,17)18;1-14(2,3)11-12-15-8-7-13(16-12)17-9-5-4-6-10-17;1-13(2,3)9-10-8-12(16-15-10)11-6-4-5-7-14-11;1-11(2,3)7-9-5-6-10(15-8-9)12(4,13)14;1-10(2)9-11-13-4-3-12(14-11)15-5-7-16-8-6-15;1-10(2,3)7-8-5-4-6-9(15-8)11(12,13)14;1-10(2,3)7-9-14-6-5-8(15-9)11(4,12)13;1-11(2,3)7-8-12-9(14-4)6-10(13-8)15-5;1-11(2,3)7-9-12-13-10(14-9)8-5-4-6-8;1-11(2,3)7-9-5-4-6-10(8-12)13-9;1-8(2)7-9-11-6-5-10(12-9)13(3)4;1-10(2,3)7-8-11-6-5-9(12-8)13-4;1-8-6-11-7-9(12-8)5-10(2,3)4;1-8-5-6-11-9(12-8)7-10(2,3)4;1-7(2)4-9-6-10-8(3)5-11-9/h5-6,8-10H,7H2,1-4H3;7-8H,4-6,9-11H2,1-3H3;4-8H,9H2,1-3H3;5-6,8H,7H2,1-4H3;3-4,10H,5-9H2,1-2H3;4-6H,7H2,1-3H3;5-6H,7H2,1-4H3;6H,7H2,1-5H3;8H,4-7H2,1-3H3;4-6H,7H2,1-3H3;5-6,8H,7H2,1-4H3;5-6H,7H2,1-4H3;6-7H,5H2,1-4H3;5-6H,7H2,1-4H3;5-7H,4H2,1-3H3
InChIKeyHCSTYHDUSJOJFN-UHFFFAOYSA-N
XLogP40.87
TPSA457.63 Ų
H-Bond Donors
H-Bond Acceptors38
Rotatable Bonds30
Heavy Atoms218
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5003024.10
LogP ≤ 540.87
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1038

Analyze 2-cyclobutyl-5-(2,2-dimethylpropyl)-1,3,4-oxadiazole;2-(1,1-difluoroethyl)-5-(2,2-dimethylpropyl)pyridine;4-(1,1-difluoroethyl)-2-(2,2-dimethylpropyl)pyrimidine;5-[6-(1,1-difluoroethyl)-3-pyridinyl]-2-(2,2-dimethylpropyl)pyrimidine;N,N-dimethyl-2-(2-methylpropyl)pyrimidin-4-amine;2-(2,2-dimethylpropyl)-4,6-dimethoxypyrimidine;2-(2,2-dimethylpropyl)-4-methoxypyrimidine;2-(2,2-dimethylpropyl)-6-methylpyrazine;2-(2,2-dimethylpropyl)-4-methylpyrimidine;2-(2,2-dimethylpropyl)-4-piperidin-1-ylpyrimidine;6-(2,2-dimethylpropyl)pyridine-2-carbonitrile;3-(2,2-dimethylpropyl)-5-pyridin-2-yl-1,2-oxazole;2-(2,2-dimethylpropyl)-6-(trifluoromethyl)pyridine;2-methyl-5-(2-methylpropyl)pyrazine;4-[2-(2-methylpropyl)pyrimidin-4-yl]morpholine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-cyclobutyl-5-(2,2-dimethylpropyl)-1,3,4-oxadiazole;2-(1,1-difluoroethyl)-5-(2,2-dimethylpropyl)pyridine;4-(1,1-difluoroethyl)-2-(2,2-dimethylpropyl)pyrimidine;5-[6-(1,1-difluoroethyl)-3-pyridinyl]-2-(2,2-dimethylpropyl)pyrimidine;N,N-dimethyl-2-(2-methylpropyl)pyrimidin-4-amine;2-(2,2-dimethylpropyl)-4,6-dimethoxypyrimidine;2-(2,2-dimethylpropyl)-4-methoxypyrimidine;2-(2,2-dimethylpropyl)-6-methylpyrazine;2-(2,2-dimethylpropyl)-4-methylpyrimidine;2-(2,2-dimethylpropyl)-4-piperidin-1-ylpyrimidine;6-(2,2-dimethylpropyl)pyridine-2-carbonitrile;3-(2,2-dimethylpropyl)-5-pyridin-2-yl-1,2-oxazole;2-(2,2-dimethylpropyl)-6-(trifluoromethyl)pyridine;2-methyl-5-(2-methylpropyl)pyrazine;4-[2-(2-methylpropyl)pyrimidin-4-yl]morpholine?
The IUPAC name of 2-cyclobutyl-5-(2,2-dimethylpropyl)-1,3,4-oxadiazole;2-(1,1-difluoroethyl)-5-(2,2-dimethylpropyl)pyridine;4-(1,1-difluoroethyl)-2-(2,2-dimethylpropyl)pyrimidine;5-[6-(1,1-difluoroethyl)-3-pyridinyl]-2-(2,2-dimethylpropyl)pyrimidine;N,N-dimethyl-2-(2-methylpropyl)pyrimidin-4-amine;2-(2,2-dimethylpropyl)-4,6-dimethoxypyrimidine;2-(2,2-dimethylpropyl)-4-methoxypyrimidine;2-(2,2-dimethylpropyl)-6-methylpyrazine;2-(2,2-dimethylpropyl)-4-methylpyrimidine;2-(2,2-dimethylpropyl)-4-piperidin-1-ylpyrimidine;6-(2,2-dimethylpropyl)pyridine-2-carbonitrile;3-(2,2-dimethylpropyl)-5-pyridin-2-yl-1,2-oxazole;2-(2,2-dimethylpropyl)-6-(trifluoromethyl)pyridine;2-methyl-5-(2-methylpropyl)pyrazine;4-[2-(2-methylpropyl)pyrimidin-4-yl]morpholine (CID 158440305) is 2-cyclobutyl-5-(2,2-dimethylpropyl)-1,3,4-oxadiazole;2-(1,1-difluoroethyl)-5-(2,2-dimethylpropyl)pyridine;4-(1,1-difluoroethyl)-2-(2,2-dimethylpropyl)pyrimidine;5-[6-(1,1-difluoroethyl)-3-pyridinyl]-2-(2,2-dimethylpropyl)pyrimidine;N,N-dimethyl-2-(2-methylpropyl)pyrimidin-4-amine;2-(2,2-dimethylpropyl)-4,6-dimethoxypyrimidine;2-(2,2-dimethylpropyl)-4-methoxypyrimidine;2-(2,2-dimethylpropyl)-6-methylpyrazine;2-(2,2-dimethylpropyl)-4-methylpyrimidine;2-(2,2-dimethylpropyl)-4-piperidin-1-ylpyrimidine;6-(2,2-dimethylpropyl)pyridine-2-carbonitrile;3-(2,2-dimethylpropyl)-5-pyridin-2-yl-1,2-oxazole;2-(2,2-dimethylpropyl)-6-(trifluoromethyl)pyridine;2-methyl-5-(2-methylpropyl)pyrazine;4-[2-(2-methylpropyl)pyrimidin-4-yl]morpholine.
What is the SMILES notation for 2-cyclobutyl-5-(2,2-dimethylpropyl)-1,3,4-oxadiazole;2-(1,1-difluoroethyl)-5-(2,2-dimethylpropyl)pyridine;4-(1,1-difluoroethyl)-2-(2,2-dimethylpropyl)pyrimidine;5-[6-(1,1-difluoroethyl)-3-pyridinyl]-2-(2,2-dimethylpropyl)pyrimidine;N,N-dimethyl-2-(2-methylpropyl)pyrimidin-4-amine;2-(2,2-dimethylpropyl)-4,6-dimethoxypyrimidine;2-(2,2-dimethylpropyl)-4-methoxypyrimidine;2-(2,2-dimethylpropyl)-6-methylpyrazine;2-(2,2-dimethylpropyl)-4-methylpyrimidine;2-(2,2-dimethylpropyl)-4-piperidin-1-ylpyrimidine;6-(2,2-dimethylpropyl)pyridine-2-carbonitrile;3-(2,2-dimethylpropyl)-5-pyridin-2-yl-1,2-oxazole;2-(2,2-dimethylpropyl)-6-(trifluoromethyl)pyridine;2-methyl-5-(2-methylpropyl)pyrazine;4-[2-(2-methylpropyl)pyrimidin-4-yl]morpholine?
The canonical SMILES for 2-cyclobutyl-5-(2,2-dimethylpropyl)-1,3,4-oxadiazole;2-(1,1-difluoroethyl)-5-(2,2-dimethylpropyl)pyridine;4-(1,1-difluoroethyl)-2-(2,2-dimethylpropyl)pyrimidine;5-[6-(1,1-difluoroethyl)-3-pyridinyl]-2-(2,2-dimethylpropyl)pyrimidine;N,N-dimethyl-2-(2-methylpropyl)pyrimidin-4-amine;2-(2,2-dimethylpropyl)-4,6-dimethoxypyrimidine;2-(2,2-dimethylpropyl)-4-methoxypyrimidine;2-(2,2-dimethylpropyl)-6-methylpyrazine;2-(2,2-dimethylpropyl)-4-methylpyrimidine;2-(2,2-dimethylpropyl)-4-piperidin-1-ylpyrimidine;6-(2,2-dimethylpropyl)pyridine-2-carbonitrile;3-(2,2-dimethylpropyl)-5-pyridin-2-yl-1,2-oxazole;2-(2,2-dimethylpropyl)-6-(trifluoromethyl)pyridine;2-methyl-5-(2-methylpropyl)pyrazine;4-[2-(2-methylpropyl)pyrimidin-4-yl]morpholine is CC(C)(C)Cc1cc(-c2ccccn2)on1.CC(C)(C)Cc1ccc(C(C)(F)F)nc1.CC(C)(C)Cc1cccc(C#N)n1.CC(C)(C)Cc1cccc(C(F)(F)F)n1.CC(C)(C)Cc1ncc(-c2ccc(C(C)(F)F)nc2)cn1.CC(C)(C)Cc1nccc(C(C)(F)F)n1.CC(C)(C)Cc1nccc(N2CCCCC2)n1.CC(C)(C)Cc1nnc(C2CCC2)o1.CC(C)Cc1nccc(N(C)C)n1.CC(C)Cc1nccc(N2CCOCC2)n1.COc1cc(OC)nc(CC(C)(C)C)n1.COc1ccnc(CC(C)(C)C)n1.Cc1ccnc(CC(C)(C)C)n1.Cc1cnc(CC(C)C)cn1.Cc1cncc(CC(C)(C)C)n1.
What is the InChIKey of 2-cyclobutyl-5-(2,2-dimethylpropyl)-1,3,4-oxadiazole;2-(1,1-difluoroethyl)-5-(2,2-dimethylpropyl)pyridine;4-(1,1-difluoroethyl)-2-(2,2-dimethylpropyl)pyrimidine;5-[6-(1,1-difluoroethyl)-3-pyridinyl]-2-(2,2-dimethylpropyl)pyrimidine;N,N-dimethyl-2-(2-methylpropyl)pyrimidin-4-amine;2-(2,2-dimethylpropyl)-4,6-dimethoxypyrimidine;2-(2,2-dimethylpropyl)-4-methoxypyrimidine;2-(2,2-dimethylpropyl)-6-methylpyrazine;2-(2,2-dimethylpropyl)-4-methylpyrimidine;2-(2,2-dimethylpropyl)-4-piperidin-1-ylpyrimidine;6-(2,2-dimethylpropyl)pyridine-2-carbonitrile;3-(2,2-dimethylpropyl)-5-pyridin-2-yl-1,2-oxazole;2-(2,2-dimethylpropyl)-6-(trifluoromethyl)pyridine;2-methyl-5-(2-methylpropyl)pyrazine;4-[2-(2-methylpropyl)pyrimidin-4-yl]morpholine?
The InChIKey is HCSTYHDUSJOJFN-UHFFFAOYSA-N. The full InChI is InChI=1S/C16H19F2N3.C14H23N3.C13H16N2O.C12H17F2N.C12H19N3O.C11H14F3N.C11H16F2N2.C11H18N2O2.C11H18N2O.C11H14N2.C10H17N3.C10H16N2O.2C10H16N2.C9H14N2/c1-15(2,3)7-14-20-9-12(10-21-14)11-5-6-13(19-8-11)16(4,17)18;1-14(2,3)11-12-15-8-7-13(16-12)17-9-5-4-6-10-17;1-13(2,3)9-10-8-12(16-15-10)11-6-4-5-7-14-11;1-11(2,3)7-9-5-6-10(15-8-9)12(4,13)14;1-10(2)9-11-13-4-3-12(14-11)15-5-7-16-8-6-15;1-10(2,3)7-8-5-4-6-9(15-8)11(12,13)14;1-10(2,3)7-9-14-6-5-8(15-9)11(4,12)13;1-11(2,3)7-8-12-9(14-4)6-10(13-8)15-5;1-11(2,3)7-9-12-13-10(14-9)8-5-4-6-8;1-11(2,3)7-9-5-4-6-10(8-12)13-9;1-8(2)7-9-11-6-5-10(12-9)13(3)4;1-10(2,3)7-8-11-6-5-9(12-8)13-4;1-8-6-11-7-9(12-8)5-10(2,3)4;1-8-5-6-11-9(12-8)7-10(2,3)4;1-7(2)4-9-6-10-8(3)5-11-9/h5-6,8-10H,7H2,1-4H3;7-8H,4-6,9-11H2,1-3H3;4-8H,9H2,1-3H3;5-6,8H,7H2,1-4H3;3-4,10H,5-9H2,1-2H3;4-6H,7H2,1-3H3;5-6H,7H2,1-4H3;6H,7H2,1-5H3;8H,4-7H2,1-3H3;4-6H,7H2,1-3H3;5-6,8H,7H2,1-4H3;5-6H,7H2,1-4H3;6-7H,5H2,1-4H3;5-6H,7H2,1-4H3;5-7H,4H2,1-3H3.
What are the key properties of 2-cyclobutyl-5-(2,2-dimethylpropyl)-1,3,4-oxadiazole;2-(1,1-difluoroethyl)-5-(2,2-dimethylpropyl)pyridine;4-(1,1-difluoroethyl)-2-(2,2-dimethylpropyl)pyrimidine;5-[6-(1,1-difluoroethyl)-3-pyridinyl]-2-(2,2-dimethylpropyl)pyrimidine;N,N-dimethyl-2-(2-methylpropyl)pyrimidin-4-amine;2-(2,2-dimethylpropyl)-4,6-dimethoxypyrimidine;2-(2,2-dimethylpropyl)-4-methoxypyrimidine;2-(2,2-dimethylpropyl)-6-methylpyrazine;2-(2,2-dimethylpropyl)-4-methylpyrimidine;2-(2,2-dimethylpropyl)-4-piperidin-1-ylpyrimidine;6-(2,2-dimethylpropyl)pyridine-2-carbonitrile;3-(2,2-dimethylpropyl)-5-pyridin-2-yl-1,2-oxazole;2-(2,2-dimethylpropyl)-6-(trifluoromethyl)pyridine;2-methyl-5-(2-methylpropyl)pyrazine;4-[2-(2-methylpropyl)pyrimidin-4-yl]morpholine?
2-cyclobutyl-5-(2,2-dimethylpropyl)-1,3,4-oxadiazole;2-(1,1-difluoroethyl)-5-(2,2-dimethylpropyl)pyridine;4-(1,1-difluoroethyl)-2-(2,2-dimethylpropyl)pyrimidine;5-[6-(1,1-difluoroethyl)-3-pyridinyl]-2-(2,2-dimethylpropyl)pyrimidine;N,N-dimethyl-2-(2-methylpropyl)pyrimidin-4-amine;2-(2,2-dimethylpropyl)-4,6-dimethoxypyrimidine;2-(2,2-dimethylpropyl)-4-methoxypyrimidine;2-(2,2-dimethylpropyl)-6-methylpyrazine;2-(2,2-dimethylpropyl)-4-methylpyrimidine;2-(2,2-dimethylpropyl)-4-piperidin-1-ylpyrimidine;6-(2,2-dimethylpropyl)pyridine-2-carbonitrile;3-(2,2-dimethylpropyl)-5-pyridin-2-yl-1,2-oxazole;2-(2,2-dimethylpropyl)-6-(trifluoromethyl)pyridine;2-methyl-5-(2-methylpropyl)pyrazine;4-[2-(2-methylpropyl)pyrimidin-4-yl]morpholine has a molecular weight of 3024.10 g/mol, XLogP of 40.87, 30 rotatable bonds, 0 hydrogen bond donors, and 38 hydrogen bond acceptors.
Where does this data come from?
All data for 2-cyclobutyl-5-(2,2-dimethylpropyl)-1,3,4-oxadiazole;2-(1,1-difluoroethyl)-5-(2,2-dimethylpropyl)pyridine;4-(1,1-difluoroethyl)-2-(2,2-dimethylpropyl)pyrimidine;5-[6-(1,1-difluoroethyl)-3-pyridinyl]-2-(2,2-dimethylpropyl)pyrimidine;N,N-dimethyl-2-(2-methylpropyl)pyrimidin-4-amine;2-(2,2-dimethylpropyl)-4,6-dimethoxypyrimidine;2-(2,2-dimethylpropyl)-4-methoxypyrimidine;2-(2,2-dimethylpropyl)-6-methylpyrazine;2-(2,2-dimethylpropyl)-4-methylpyrimidine;2-(2,2-dimethylpropyl)-4-piperidin-1-ylpyrimidine;6-(2,2-dimethylpropyl)pyridine-2-carbonitrile;3-(2,2-dimethylpropyl)-5-pyridin-2-yl-1,2-oxazole;2-(2,2-dimethylpropyl)-6-(trifluoromethyl)pyridine;2-methyl-5-(2-methylpropyl)pyrazine;4-[2-(2-methylpropyl)pyrimidin-4-yl]morpholine is sourced from PubChem (CID 158440305), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).